Virpax Pharmaceuticals, Inc.

NasdaqCM:VRPX Stock Report

Market Cap: US$3.7m

Virpax Pharmaceuticals Management

Management criteria checks 2/4

Virpax Pharmaceuticals' CEO is Gerald Bruce, appointed in Nov 2023, has a tenure of less than a year. total yearly compensation is $432.87K, comprised of 8.8% salary and 91.2% bonuses, including company stock and options. directly owns 0.034% of the company’s shares, worth $1.28K. The average tenure of the management team and the board of directors is 1.9 years and 3.8 years respectively.

Key information

Gerald Bruce

Chief executive officer

US$432.9k

Total compensation

CEO salary percentage8.8%
CEO tenureless than a year
CEO ownership0.03%
Management average tenure1.9yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

Virpax Pharmaceuticals GAAP EPS of -$0.50 misses by $0.06

Aug 15

Virpax: Targeting Pain At Its Source

Sep 04

Virpax Pharmaceuticals shares surge on Envelta IND update

Jun 21

CEO Compensation Analysis

How has Gerald Bruce's remuneration changed compared to Virpax Pharmaceuticals's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2023US$433kUS$38k

-US$15m

Sep 30 2023n/an/a

-US$14m

Jun 30 2023n/an/a

-US$15m

Mar 31 2023n/an/a

-US$18m

Dec 31 2022US$80kn/a

-US$22m

Compensation vs Market: Gerald's total compensation ($USD432.87K) is below average for companies of similar size in the US market ($USD667.11K).

Compensation vs Earnings: Gerald's compensation has increased whilst the company is unprofitable.


CEO

Gerald Bruce (66 yo)

less than a year

Tenure

US$432,874

Compensation

Mr. Gerald W. Bruce served as Executive Vice President of Commercial Operations at Virpax Pharmaceuticals, Inc. since August 2017 until November 17, 2023 and serves as Chief Executive Officer since Novembe...


Leadership Team

NamePositionTenureCompensationOwnership
Gerald Bruce
CEO & Directorless than a yearUS$432.87k0.034%
$ 1.3k
Sheila Mathias
Chief Scientific Officer3yrsUS$773.97kno data
Jeffrey Gudin
Executive VP7.3yrsUS$192.00k0.065%
$ 2.4k
Vinay Shah
CFO, Principal Financial Officerless than a yearno datano data
Shana Panzarella
Chief of Staffno datano datano data

1.9yrs

Average Tenure

58.5yo

Average Age

Experienced Management: VRPX's management team is not considered experienced ( 1.9 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Gerald Bruce
CEO & Director2.8yrsUS$432.87k0.034%
$ 1.3k
Jeffrey Gudin
Executive VPno dataUS$192.00k0.065%
$ 2.4k
Eric Floyd
Independent Chairman7.3yrsUS$71.00k0.068%
$ 2.5k
Jerrold Sendrow
Independent Director7.3yrsUS$65.00k0.077%
$ 2.8k
Barbara Ruskin
Independent Director1.1yrsno datano data
Thani Jambulingam
Independent Director7.3yrsUS$69.00k0.0085%
$ 316.1
Vanila Singh
Independent Director3.8yrsUS$65.00k0%
$ 0
Michael Dubin
Independent Director2.8yrsUS$65.60k0%
$ 0

3.8yrs

Average Tenure

61yo

Average Age

Experienced Board: VRPX's board of directors are considered experienced (3.8 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.